FDA Investigator James E Trabert
James E Trabert has conducted inspections on 114 sites in 3 countries as of 17 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
114
Last Inspection Date:
17 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Turkey,
Italy
FDA Investigators that have inspected at least one site in common with James E Trabert:
Aaron J Poloni,
Abby M Miller,
Abigail A Andersen,
Adam S Freeman,
Amy R Glynn,
Andrew K Haack, PhD,
Anh Trinh T Nguyen,
Aric M Sonnenschein,
Arie R Dyk,
Ashar P Parikh,
Ashleigh P Barkans,
Avery J Dennis,
Barbara J Rincon,
Belinda E Clifton,
Brenda K Alford,
Bruce R Burrell,
Camille Bennett Hoffman,
Catherine J Laufmann,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Ce'nedra M Martin,
Celia L Hutchinstein,
Christopher M Elliott,
Christopher R Czajka,
Christopher S Genther,
Creighton T Tuzon,
Crystal A Harlan,
Cynthia L Gorveatt,
David A Quale,
David J Gomes,
David J Hajduk,
Dawn E Barkans,
Deborah K Richardson,
Debra D Devlieger,
Debra J Fracassa,
Denise H Howell,
Dennis R Hudson,
Devon M Shoop,
Dewey W Darold,
Diane R Lirhus,
Dianne B Latona,
Dirk L Lincoln,
Donald B Mckechnie,
Eileen T Dupont,
Elizabeth S Howell,
Emanual A Kahsai,
Eric C Milstead,
Eric L Scott,
Erica R Mahone,
Fe Q Reyes,
Gary S Condrey,
Gavin W Pierce,
Gerard Pde Leon,
Gina C Collins,
Gordon Chu,
Gordon T Wales,
Hanna L Potter,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hughes,
Hyeongho Ha,
Ian J Thomson,
Indigo A Doll,
Jacob N Hamilton,
James I Vik,
James S Cartwright,
Jane M Kreis,
Jane S Wernberg,
Jason T Lovelady,
Jazmine M Welcher,
Jean Brewer,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeff A Gard,
Jeff M Uriarte,
Jeffery A Johnson,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jessica L Andrade,
Jessica L Friedt,
Jessie J Deloach,
Jinkee Mvila Binayug,
Joanne M Fukuda,
John A Liu,
John E Emmert,
John T Sproul,
John W Banks,
Joie A Riehle,
Jonathan T Little,
Jose O Caraballo Rivera,
Joseph A Seitz, III,
Joseph C Francisco,
Joseph C Yen,
Joseph H Lam,
Joseph M Hudak,
Joseph Tibay,
Judy C Nepsa,
Julia E Chervoni,
Karla J Gibler,
Katharine Chan,
Katherine L Arnold,
Keegan B Mixon,
Keishla M Arroyo Lopez,
Kelsey A Hustedt,
Kelsey A Volkman,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Kimberly Jproctor Jones,
Kristina M Phelps,
Lakecha N Lewis,
Lance W Bohm,
Laura Kathryn,
Lawrence Y Lee, PhD,
LCDR Ismael Olvera, IV,
Lenita R Silvera,
Lesley A Swanson,
Lester O Boian,
Leya A Grosch,
Lisa A Bowden,
Lon A Cummings,
Lori J Jennings,
Lori J Silverstein,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Marsha L Mccauley,
Matthew R Barr,
Maurice M Sheehan,
Mcgrewp,
Michael F Schuette,
Michael J Donovan,
Michael J Lackey,
Michael S Valenzuela,
Mikel T Wright,
Misty L Wallace,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Ngoc Lan T Nguyen,
Nianna C Burns,
Othello G Capangpangan,
Patrick R Brown,
Paul F Rader,
Peter Kessler, PhD,
Peter T Regan,
Rachelle M Deskins,
Rebecca A Sletner,
Rebecca T Davis,
Richard A Martin,
Richard G Runyon,
Rita E Luttrell,
Robert A Williams,
Robert F Hennes,
Robert J Vezzetti,
Rocco C Black,
Roger F Zabinski,
Roger J Adams,
Ronald E Gill,
Ronald L Lahti,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Sara M Richardson,
Sarah L Clark,
Scott W Fox,
Sharon I Gundersen,
Sharon K Ferguson,
Shelagh D Schopen,
Stephanie A Slater, MS,
Stephanie J Shaw,
Sundy V Sedwick,
Sylvia A Thomas,
Tamara L Alexander,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy D Evans,
Timothy S Williamson,
Trushani T Desai,
Vitaliy N Guyvan,
Wayne D Stowell,
William A Burkey,
Willis L Hicks,
Wolfgang F Povolny,
Zachary P Wachlarowicz
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more